Belgium: Temporary VAT relief measures; medical supplies and real estate and construction sectors (COVID-19)
Belgium: Temporary VAT relief measures
The parliament on 17 December 2020 passed legislation providing temporary value added tax (VAT) relief measures in response to the coronavirus (COVID-19) pandemic.
The VAT measures specifically are intended to provide better and cheaper access to preventive medical supplies and to stimulate the real estate and construction sectors. The provisions include:
- An extension of the reduced VAT rate of 6% through 31 March 2021 with respect to the supply, intra-Community acquisition, and import of certain types of mouth masks and hydroalcoholic gels.
- Introduction of the reduced VAT rate of 0% to be applied to the supply, intra-Community acquisition, and import of COVID-19 vaccines and medical aid devices for in-vitro diagnostics of the COVID-19 disease, as well as to services closely related to these vaccines and devices. This measure will be applicable in the period between 1 January 2021 and 31 December 2022.
- Broadened scope of application of the reduced VAT rate of 6% for the demolition and reconstruction of real estate for the period between 1 January 2021 and 31 December 2022.
Read a December 2020 report prepared by the KPMG member firm in Belgium
© 2022 KPMG LLP, a Delaware limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
For more detail about the structure of the KPMG global organization please visit https://home.kpmg/governance.
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.